BHD-associated kidney cancer is an indolent tumor as shown in Figure 3B. In addition, we observed transcriptomic intratumor heterogeneity (tITH) and increased intercalated cell characteristics with upregulated FOXI1-driven genes in BHD-associated kidney cancer. This evidence concerns the gene FOXI1 and kidney cancer.